You’ve probably been mulling over which office chair to buy for yourself or a co-worker with Ehlers-Danlos syndrome. There are a variety of choices on the market, including the Aloria, Nouhaus Ergo3D Mesh, Respawn Specters, and Staples Sorina. Depending on the severity of your condition, these options may not be ideal, but they’re certainly worth considering.
The Aloria office chair is a modern classic, and its features are highly adjustable. This chair includes virtually every adjustable feature, including lumbar support, tilt, swivel, headrest height, and arm rests. Additionally, the chair is affordable, so it makes sense for anyone looking to save money while obtaining the best possible chair for them. Read on to learn more.
Nouhaus Ergo3D Mesh
The Nouhaus Ergo3D mesh office chair is a great choice for those who suffer from Ehlers Danlos or have a history of spinal disorders. This chair’s innovative back design is intuitive, allowing the user to adjust the seat depth and lumbar support. It is sturdy, but not overly heavy. The mesh upholstery is comfortable, and the ergonomic design is easy to adjust.
The Respawn Specter has three-part contoured full-mesh back and seat. This creates a weightless feel, and its three-d adjustable armrests help keep your back and neck aligned. It also features synchro-tilt, which allows you to keep your front edge of the seat closer to the floor. This feature opens the torso’s angle and promotes better circulation. You can also control the speed of the recline with tilt tension.
A bonded leather seat and padded back are the highlights of the Sorina office chair. Comfortable cushioning provides lumbar support and head support for your neck and head. The chair is equipped with tilt tension and tilt lock features for your personal comfort. The arms are adjustable for maximum support. A tilt tension lever prevents the chair from leaning too far and a tilt lock keeps it in place when not in use. The chair is made to withstand up to 275 pounds.
A recent study has identified a genetic mutation called COL3A1 as a possible cause of vascular Ehlers-Danlos syndrome (EDS). It was the first report of vascular Ehlers-Danslos syndrome. It was based on the clinical features of a patient with this genetic disorder. This study also describes the role of genetic testing in the diagnosis of Ehlers-Danlos syndrome.